Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $7,386 | 303 | 98.4% |
| Education | $122.85 | 4 | 1.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Boston Scientific Corporation | $1,067 | 12 | $0 (2020) |
| Abbott Laboratories | $1,017 | 14 | $0 (2022) |
| Novartis Pharmaceuticals Corporation | $689.61 | 85 | $0 (2022) |
| Biosense Webster, Inc. | $665.80 | 6 | $0 (2020) |
| Janssen Pharmaceuticals, Inc | $625.61 | 47 | $0 (2022) |
| Amgen Inc. | $445.81 | 23 | $0 (2022) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $345.10 | 10 | $0 (2019) |
| SANOFI-AVENTIS U.S. LLC | $340.91 | 12 | $0 (2020) |
| E.R. Squibb & Sons, L.L.C. | $233.40 | 16 | $0 (2022) |
| Amarin Pharma Inc. | $205.26 | 6 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $17.47 | 1 | Boehringer Ingelheim Pharmaceuticals, Inc. ($17.47) |
| 2022 | $408.85 | 13 | Abbott Laboratories ($163.61) |
| 2021 | $609.86 | 35 | Janssen Pharmaceuticals, Inc ($156.07) |
| 2020 | $854.59 | 23 | Abbott Laboratories ($210.70) |
| 2019 | $2,280 | 83 | Biosense Webster, Inc. ($358.17) |
| 2018 | $1,387 | 73 | Novartis Pharmaceuticals Corporation ($189.28) |
| 2017 | $1,951 | 79 | BOSTON SCIENTIFIC CORPORATION ($553.45) |
All Payment Transactions
307 individual payment records from CMS Open Payments — Page 1 of 13
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 05/28/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $17.47 | General |
| Category: DIABETES | ||||||
| 07/29/2022 | Abbott Laboratories | QUADRA ALLURE MP (Device) | Food and Beverage | In-kind items and services | $141.22 | General |
| Category: Cardiac Rhythm Management | ||||||
| 06/15/2022 | Bardy Diagnostics, Inc. | Carnation Ambulatory Monitor (Device) | Food and Beverage | In-kind items and services | $15.00 | General |
| Category: Cardiac Arrhythmia Monitoring | ||||||
| 05/31/2022 | Abbott Laboratories | CARDIOMEMS (Device) | Food and Beverage | In-kind items and services | $22.39 | General |
| Category: Heart Failure | ||||||
| 04/28/2022 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $22.89 | General |
| Category: Cardiology | ||||||
| 04/27/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $18.30 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 04/27/2022 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $16.72 | General |
| Category: Cardiovascular | ||||||
| 04/07/2022 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $14.98 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 03/30/2022 | Merck Sharp & Dohme LLC | VERQUVO (Drug) | Food and Beverage | In-kind items and services | $72.76 | General |
| Category: CARDIOVASCULAR | ||||||
| 02/22/2022 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $18.52 | General |
| Category: CARDIOVASCULAR | ||||||
| 02/16/2022 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $16.05 | General |
| Category: Cardiovascular | ||||||
| 02/02/2022 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $13.36 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 01/19/2022 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $20.59 | General |
| Category: CARDIOVASCULAR | ||||||
| 01/12/2022 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $16.07 | General |
| Category: Cardiology | ||||||
| 12/23/2021 | Merck Sharp & Dohme Corporation | VERQUVO (Drug) | Food and Beverage | In-kind items and services | $11.26 | General |
| Category: CARDIOVASCULAR | ||||||
| 12/22/2021 | Abbott Laboratories | CardioMEMS HF System (Device) | Food and Beverage | In-kind items and services | $28.67 | General |
| Category: Heart Failure | ||||||
| 12/22/2021 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $20.85 | General |
| Category: CARDIOVASCULAR | ||||||
| 12/02/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $7.94 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 12/01/2021 | Merck Sharp & Dohme Corporation | VERQUVO (Drug) | Food and Beverage | In-kind items and services | $11.28 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/11/2021 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $12.93 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 10/15/2021 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $23.99 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/11/2021 | PFIZER INC. | ELIQUIS (Drug), VYNDAQEL | Food and Beverage | In-kind items and services | $18.31 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 10/03/2021 | Abbott Laboratories | CardioMEMS HF System (Device) | Food and Beverage | In-kind items and services | $22.06 | General |
| Category: Heart Failure | ||||||
| 10/03/2021 | Abbott Laboratories | CardioMEMS HF System (Device) | Food and Beverage | In-kind items and services | $20.68 | General |
| Category: Heart Failure | ||||||
| 09/27/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $5.82 | General |
| Category: Cardiovascular & Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2022 | 4 | 462 | 500 | $59,104 | $14,818 |
| 2021 | 11 | 1,959 | 3,167 | $384,980 | $138,463 |
| 2020 | 12 | 2,820 | 4,432 | $734,353 | $240,626 |
All Medicare Procedures & Services
27 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 182 | 202 | $34,561 | $8,900 | 25.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 71 | 77 | $17,532 | $4,622 | 26.4% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 163 | 164 | $5,652 | $1,057 | 18.7% |
| 93793 | Anticoagulant management of patient taking warfarin | Office | 2022 | 46 | 57 | $1,359 | $239.58 | 17.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 341 | 429 | $92,664 | $41,327 | 44.6% |
| 93306 | Ultrasound examination of heart including color-depicted blood flow rate, direction, and valve function | Office | 2021 | 281 | 285 | $130,530 | $38,201 | 29.3% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 420 | 605 | $92,565 | $35,426 | 38.3% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2021 | 486 | 694 | $23,596 | $7,010 | 29.7% |
| 99211 | Established patient outpatient visit, minimal presenting problem | Office | 2021 | 78 | 352 | $14,432 | $4,875 | 33.8% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 32 | 33 | $9,570 | $4,624 | 48.3% |
| 93793 | Anti-clotting management for patient taking warfarin | Office | 2021 | 174 | 343 | $8,232 | $2,742 | 33.3% |
| 99202 | New patient outpatient visit, total time 15-29 minutes | Office | 2021 | 42 | 42 | $6,450 | $1,960 | 30.4% |
| 85610 | Blood test, clotting time | Office | 2021 | 80 | 359 | $3,949 | $1,540 | 39.0% |
| 93015 | Exercise or drug-induced heart and blood vessel stress test with ekg monitoring, physician supervision, interpretation, and report | Office | 2021 | 12 | 12 | $1,848 | $487.96 | 26.4% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 13 | 13 | $1,144 | $268.66 | 23.5% |
| 93306 | Ultrasound examination of heart including color-depicted blood flow rate, direction, and valve function | Office | 2020 | 937 | 958 | $438,764 | $139,762 | 31.9% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 540 | 879 | $130,539 | $43,716 | 33.5% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 296 | 403 | $87,048 | $30,146 | 34.6% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2020 | 586 | 817 | $27,778 | $9,148 | 32.9% |
| 99211 | Established patient office or other outpatient visit, typically 5 minutes | Office | 2020 | 111 | 526 | $21,566 | $8,372 | 38.8% |
| 85610 | Blood test, clotting time | Office | 2020 | 112 | 541 | $5,951 | $2,304 | 38.7% |
| 99202 | New patient office or other outpatient visit, typically 20 minutes | Office | 2020 | 53 | 53 | $7,990 | $2,264 | 28.3% |
| 93793 | Anti-clotting management for patient taking warfarin | Office | 2020 | 121 | 189 | $4,536 | $1,709 | 37.7% |
| 93880 | Ultrasound scanning of blood flow (outside the brain) on both sides of head and neck | Office | 2020 | 12 | 12 | $4,873 | $1,424 | 29.2% |
| 93015 | Exercise or drug-induced heart and blood vessel stress test with ekg monitoring, physician supervision, interpretation, and report | Office | 2020 | 22 | 22 | $3,388 | $1,113 | 32.8% |
About Dr. Jan Prasad, MD
Dr. Jan Prasad, MD is a Interventional Cardiology healthcare provider based in Phoenix, Arizona. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/16/2005. The National Provider Identifier (NPI) number assigned to this provider is 1841276334.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jan Prasad, MD has received a total of $7,509 in payments from pharmaceutical and medical device companies, with $17.47 received in 2024. These payments were reported across 307 transactions from 36 companies. The most common payment nature is "Food and Beverage" ($7,386).
As a Medicare-enrolled provider, Prasad has provided services to 5,241 Medicare beneficiaries, totaling 8,099 services with total Medicare billing of $393,907. Data is available for 3 years (2020–2022), covering 27 distinct procedure/service records.
Practice Information
- Specialty Interventional Cardiology
- Other Specialties Cardiovascular Disease
- Location Phoenix, AZ
- Active Since 12/16/2005
- Last Updated 04/12/2022
- Taxonomy Code 207RI0011X
- Entity Type Individual
- NPI Number 1841276334
Products in Payments
- XARELTO (Drug) $773.00
- ENTRESTO (Drug) $689.61
- Carto 3 System (Device) $665.80
- WATCHMAN (Device) $440.83
- ELIQUIS (Drug) $396.36
- LifeVest (Device) $345.10
- CardioMEMS HF System (Device) $332.67
- PRALUENT (Drug) $324.97
- Repatha (Biological) $315.94
- CRT-Ds (Device) $240.64
- Vascepa (Drug) $205.26
- LATITUDE (Device) $203.04
- BRILINTA (Drug) $198.72
- PRALUENT (Biological) $167.85
- THE LATITUDE PATIENT MANAGEMENT SYSTEM (Device) $163.90
- Quartet CRT Lead (Device) $141.72
- QUADRA ALLURE MP (Device) $141.22
- Corlanor (Drug) $129.87
- IGT D Coronary (Device) $123.98
- Quadra Allure MP RF CRT Pacemkr (Device) $119.05
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Interventional Cardiology Doctors in Phoenix
Paul Sorajja, M.d, M.D
Interventional Cardiology — Payments: $1.3M
Dr. Nishant Gupta, M.d, M.D
Interventional Cardiology — Payments: $202,624
Dr. Suzanne Sorof, M.d, M.D
Interventional Cardiology — Payments: $78,637
Nezar Falluji, Md, MD
Interventional Cardiology — Payments: $75,829
Dr. Ahmad Jabri, Md, MD
Interventional Cardiology — Payments: $42,544
Dr. Vikram Prasad, M.d, M.D
Interventional Cardiology — Payments: $42,192